Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase. [PDF]
Frey KM +7 more
europepmc +1 more source
Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach. [PDF]
Mansouri M +17 more
europepmc +1 more source
Structural biology of HIV-1 reverse transcriptase allosteric inhibitors for drug design. [PDF]
Zhou Z +8 more
europepmc +1 more source
In silico Design of Novel HIV-1 NNRTIs Based on Combined Modeling Studies of Dihydrofuro[3,4-d]pyrimidines. [PDF]
Chen Y +6 more
europepmc +1 more source
Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. [PDF]
Lagardère P +3 more
europepmc +1 more source
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors. [PDF]
Chen XM +5 more
europepmc +1 more source
The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections. [PDF]
De Clercq E.
europepmc +1 more source
Pyrimidine-based NNRTIs in HIV therapy: advances in synthesis, potency and structure-activity relationships. [PDF]
Ali H +6 more
europepmc +1 more source
Biphenyl as a Privileged Structure in Medicinal Chemistry: Advances in Anti-Infective Drug Discovery. [PDF]
Gandi MO +3 more
europepmc +1 more source
In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches. [PDF]
Wan Y +5 more
europepmc +1 more source

